The "epidemic" of breast cancer in the U.S. - Determining the factors

ONCOLOGY

Volumn 10, Issue 4, 1996, Pages 453-462

  King, Stephanie E ^a   Schottenfeld, David ^b  

^a Department of Epidemiology ^*

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORINATED HYDROCARBON; INSECTICIDE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ANAMNESIS; BREAST TUMOR; CANCER REGISTRY; CANCER STAGING; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; MORTALITY; MUTATION; OBESITY; RADIOGRAPHY; REVIEW; RISK FACTOR; STATISTICS; SURVIVAL RATE; UNITED STATES; UTILIZATION REVIEW;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; CONTRACEPTIVES, ORAL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYDROCARBONS, CHLORINATED; INCIDENCE; INSECTICIDES; MAMMOGRAPHY; MIDDLE AGED; MUTATION; NEOPLASM STAGING; OBESITY; REPRODUCTIVE HISTORY; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 0030124511     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Ries LAG, Miller BA, Hankey BF, et al: SEER Cancer Statistics Review, 1973-1991: Tablet and Graphs. Bethesda, Maryland, National Cancer Institute, NIH publication no. 94-2789, 1994.
2. Miller BA, Feuer EJ. Hankey BF: The significance of the rising incidence of breast cancer in the United Slates. Important Adv Oncol 12:193-207, 1994.
3. Holford TR, Roush GC, McKay LA: Trends in female breast cancer in Connecticut and the United States. J Clin Epidemiol 44(1):29-39, 1991.
4. Campbell MK, Feuer EJ, Wun LM. Cohort-specific risks of developing breast cancer to age 85 in Connecticut. Epidemiology 5(3):290-296, 1994.
5. Parkin DM, Muir CS, Whelan SL, et al: Cancer Incidence in Five Continents, vol 6. Lyon, France, International Agency for Research on Cancer, IARC Scientific publication no. 120. 1992.
6. Watehouse J, Muir C, Shanmugaratnam K, et al: Cancer Incidence in Five Continents, vol 4. Lyon, France, International Agency for Research on Cancer, IARC Scientific publication no. 42, 1982.
7. Kelsey JL, Horn-Ross PL: Breast cancer: Magnitude of the problem and descriptive epidemiology. Epidemiol Rev 15(1)-7-16, 1993.
8. Moolgavkar SH: Carcinogenesis modeling: From molecular biology to epidemiology. Ann Rev Publ Health 7:151-169, 1986.
9. Shimizu H, Ross RK, Bernstein L, et al. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles county. Br J Cancer 63:963-966, 1991.
10. White E. Lee CY, Kristal AR: Evaluation of the increase in breast cancer incidence in relation to mammography use. J Nati Cancer Inst 82(19):1546-1552, 1990.
11. Feuer EJ, Wun LM. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? Am J Epidemiol 136(12) 1423-1436, 1992.
12. Lantz PM, Remington PL, Newcomb PA: Mammography screening and increased incidence of breast cancer in Wisconsin, J Natl Cancer Inst 83(21):1540-1546, 1991.
13. Liff JM, Sung JFC, Chow WH, etal: Does increased detection account for the rising incidence of breast cancer? Am J Publ Health 81(4):462-465, 1991.
14. Reeves MJ, Newcomb PA, Remington PL, et al: Determinants of breast cancer detection among Wisconsin (United States) women, 1988-1990. Cancer Causes Control 6:103-111, 1995.
15. Farwell MF, Foster RS, Constanza MC: Breast cancer and earlier detection efforts-realized and unrealized impact on stage. Arch Surg 128:510-513, 1993.
16. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 15(1).36-47, 1993.
17. Pike MC, Spicer DV, Dahiuoush L, et al: Estrogens, progesterones, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15(1).17-35, 1993
18. van Wieringen JC: Secular growth changes, in Faulkner F, Tanner JM (eds): Human Growth: A Comprehensive Treutise, vol 3, pp 307-331 New York, Plenum Press, 1986
19. White E: Projected changes in breast cancer incidence due to the trend toward delayed childbearing. Am J Publ Health 77(4):495-497, 1987
20. Hahn RA, Moolgavkar SH: Nulliparity, decade of first birth, and breast cancer in Connecticut cohorts, 1855 to 1945: An ecological study. Am J Publ Health 79(11) 1503-1507, 1989.
21. Friedenreich CM, Rohan TE: A review of physical activity and breast cancer. Epidemiology 6(3):311-317, 1995.
22. Bernstein L, Henderson BE, Hanisch R, et al. Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst 86(18):1403-1408, 1994.
23. Merzenich H, Boeing H, Wahrendorf J: Dietary fat and sports activity as determinants for age at menarche. Am J Epidemiol 138(4):217-224, 1993.
24. National Center for Health Statistics: Health, United States 1994. Hyattsville, Maryland, Public Health Service, 1995.
25. Hunter DJ, Willett WC: Diet, body build, and breast cancer. Annu Rev Nutr 14:393-418, 1994.
26. Sellers TA, Kushi LH, Pottei JD, et al: Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med 326(20).1323-1329, 1992.
27. MacDonald PC, Edman CD, Hansell DL, et al: Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol 130:448-455, 1978.
28. Kissebah AH, Freedman DS, Peins AN: Health risks of obesity. Med Clin North Am 73:111-138, 1989.
29. London SJ, Colditz GA, Stampfer MJ, et al: Prospective study of relative weight, height, and risk of breast cancer. JAMA 262(20):2853-2858, 1989
30. Prentice RL, Kakar F, Hursting S, et al: Aspects of the rationale for the Women's Health Trial. J Natl Cancer Inst 80(11):802-814, 1988.
31. Simoes EJ, Byers T, Coates RJ, et al: The association between leisure-time physical activity and dietary fat in American adults. Am J Publ Health 85(2):240-244, 1995.
32. Rock CL, Kusluski RA, Galvez MM, et al: Carotenoids induce morphological changes in human mammary epithelial cell cultures. Nutr Cancer 23.319-333, 1995.
33. Jam M, Miller AB, To T: Premorbid diet and the prognosis of women with breast cancer. J Natl Cancer Inst 86:1390-1397, 1994.
34. Rock CL, Saxe GA, Ruffin MT, et al: Carotenoids, vitamin A and estrogen receptor status in breast cancer. Nutr Cancer (in press).
35. Krinsky N: Antioxidant function of carotenoids. Free Radic Biol Med 7:617-635, 1989.
36. Krinsky N: Effects of carotenoids in cellular and animal systems. Am J Clin Nutr 53:2385-2465, 1991.
37. Schatzkin A, Longnecker MP: Alcohol and breast cancer: Where are we now and where do we go from here? Cancer 74(3:suppl):1101-1110, 1994.
38. Rosenberg L, Metzger LS, Palmer JR: Alcohol consumption and risk of breast cancer: A review of the epidemiologic evidence. Epidemiol Rev 15(1):133-144, 1993.
39. Howe G, Rohan T, Decarli A, et al: The association between alcohol and breast cancer risk: Evidence from the combined analysis of six dietary case-control studies Int J Cancer 47.707-710, 1991.
40. Reichman ME, Judd JT, Longcope C, et al: Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Insr 85(9):722-726, 1993.
41. Brinton LA, Schairer C: Estrogen replacement therapy and breast cancer risk. Epidemiol Rev 15(1):66-79, 1993.
42. Colditz GA, Hankinson SE, Hunter DJ, et at: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332(24):1589-1593, 1995.
43. Stanford JL, Weiss NS, Voigt LF, et al: Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middie-aged women. JAMA 274(2):137-142, 1995.
44. Adami HO, Persson I: Hormone replacement therapy and breast cancer. A remaining controversy? JAMA 274(2):178-179, 1995.
45. Malone KE, Daling JR, Weiss NS: Oral contraceptives in relation to breast cancer. Epidemiol Rev 15(1):80-97, 1993.
46. Romieu I, Berlin JA, Colditz G: Oral contraceptives and breast cancer: Review and metaanalysis. Cancer 66:2253-2263, 1990.
47. Krieger N, Wolff MS, Hiatt RA, et al: Breast cancer and serum organochlorines A prospective study among white, black, and Asian women. J Natl Cancer Inst 86(8).589-599, 1994.
48. Safe S: Toxicology, structure-function relationship, and human and environmental health impacts of polychlonnated biphenyls: Progress and problems. Environ Health Perspect 100:259-268, 1992.
49. Hansen LG, Jansen HT: Letters: Environmental estrogens. Science 266:526, 1994.
50. Westin JB, Richter E: The Israeli breast-cancer anomaly. Ann NY Acad Sci 609:269-279, 1990.
51. Shames LS, Munekata MT, Pike MC. Re: Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 86(21). 1642-1643, 1994.
52. Wolff MS, Toniolo PG, Lee EW, et al: Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85(8):648-652, 1993.
53. Mussalo-Rauhamaa H, Pantzat P: Selenium and DDE in breast fat of breast cancer patients: Their relationship to hormone receptors in breast tissue. J Natl Cancer Inst 85(23) 1964-1965, 1993.
54. Dewailly E, Dodin S, Verreault R, et al: High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst 86(3):232-234, 1994.
55. Rowell S, Newman B, Boyd J. et al: Inherited predisposition to breast and ovarian cancer (invited editorial). Am J Hum Genet 55:861-865, 1994.
56. Wooster R, Bignell G. Lancaster J, et al: Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792, 1995.
57. Madigan MP, Ziegler RG, Benichou J, et al: Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87(22):1681-1685, 1995.
58. Hulka BS, Stark AT: Breast cancer: Cause and prevention. Lancet 346:883-887, 1995
59. Russo J, Russo IH. Toward a physiologic approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 3:353-364, 1994.